Skip to main content

and
  1. No Access

    Article

    Allogeneic stem cell transplantation for patients with mantle cell lymphoma who failed autologous stem cell transplantation: a national survey of the SFGM-TC

    Poly-chemotherapy plus rituximab followed by autologous stem cell transplantation (auto-SCT) is standard care for untreated young patients with mantle cell lymphoma (MCL). Despite this intensive treatment, tra...

    B Tessoulin, P Ceballos, P Chevallier, D Blaise in Bone Marrow Transplantation (2016)

  2. No Access

    Article

    AMA (Assistance des malades ambulatoires) : une procédure de télémédecine appliquée à la prise en charge des lymphomes agressifs

    The prognosis of diffuse large B-cell lymphoma (DLBL) has improved with the development of new therapeutic regimes such as R-CHOP and related chemotherapy. However, these treatments are associated with adverse...

    G. Compaci, L. Obéric, L. Ysebaert, C. Borel, G. Laurent in Oncologie (2011)

  3. No Access

    Article

    Rituximab–cyclophosphamide–dexamethasone combination in the management of autoimmune cytopenias associated with chronic lymphocytic leukemia

    We report our experience on rituximab–cyclophosphamide–dexamethasone (RCD) combination therapy for the treatment of autoimmune disorders (AIDs) in 48 chronic lymphocytic leukemia (CLL) patients. Overall, 81% o...

    J Rossignol, A-S Michallet, L Oberic, M Picard, A Garon, C Willekens, R Dulery in Leukemia (2011)